Vassiliki Economides
Finanzdirektor/CFO bei GRITSTONE BIO, INC.
Vermögen: 200 764 $ am 30.04.2024
Aktive Positionen von Vassiliki Economides
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GRITSTONE BIO, INC. | Finanzdirektor/CFO | 23.06.2021 | - |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Vassiliki Economides
Ehemalige bekannte Positionen von Vassiliki Economides
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AURINIA PHARMACEUTICALS INC. | Investor Relations Kontakt | 11.07.2016 | 01.03.2019 |
Public Communications Contact | 11.07.2016 | 01.03.2019 | |
Corporate Officer/Principal | 11.07.2016 | 01.03.2019 | |
BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.03.2015 | 01.06.2016 |
KEZAR LIFE SCIENCES, INC. | Investor Relations Kontakt | 04.03.2019 | - |
Public Communications Contact | 04.03.2019 | - | |
PROSENSA HOLDING NV | Investor Relations Kontakt | - | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Investor Relations Kontakt | - | - |
Corporate Officer/Principal | - | - |
Ausbildung von Vassiliki Economides
McGill University | Undergraduate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Kanada | 4 |
Niederlande | 2 |
Operativ
Investor Relations Contact | 4 |
Corporate Officer/Principal | 3 |
Public Communications Contact | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
AURINIA PHARMACEUTICALS INC. | Health Technology |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
KEZAR LIFE SCIENCES, INC. | Health Technology |
GRITSTONE BIO, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
Altum Pharmaceuticals, Inc.
Altum Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Altum Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the clinical and commercial development of novel healthcare products for the treatment of women's gynecological neoplasia, autoimmune disorders, Hypercalcemia of Malignancy, Skeletal Related Events and Osteoporosis diseases. The company was founded in 2016 and is headquartered in Vancouver, Canada. | Health Technology |
- Börse
- Insiders
- Vassiliki Economides
- Erfahrung